Axillary Dissection

2019 ◽  
pp. 635-640
Author(s):  
Ashkaun Shaterian ◽  
Erin Lin
Keyword(s):  
Lymph Node ◽  
Axillary Lymph Node ◽  
Axillary Dissection ◽  
Lymph Node Biopsy ◽  
Malignant Neoplasms ◽  
Axillary Lymph ◽  
Node Dissection ◽  
Subclinical Disease ◽  
Therapeutic Value ◽  
Pathologic Staging

Axillary dissection represents an evaluation of the axillary lymph node basin to provide prognostic and therapeutic value for cancer patients. Axillary lymph node dissection (ALND) is most commonly utilized in breast cancer but has applications in the treatment of other malignant neoplasms that may drain to the axillary lymphatics. ALND offers pathologic staging of cancer, therapeutic removal of clinically apparent axillary disease, and the removal of lymph nodes with possible subclinical disease following sentinel lymph node biopsy. The anatomy of the axillary space and technique of axillary dissection are discussed in detail in the chapter text.

scholarly journals Epitrochlear Lymph Node Dissection and Axillary Lymph Node Biopsy. An Unusual Clinical Presentation in a Patient with Forearm Melanoma

2013 ◽  
Vol 20 (13) ◽  
pp. 4378-4378 ◽  
Author(s):  
Piero Covarelli ◽  
Gian Marco Tomassini ◽  
Alessandra Servoli ◽  
Franco Picciotto ◽  
Giuseppe Noya
Keyword(s):  
Lymph Node ◽  
Lymph Node Dissection ◽  
Axillary Lymph Node ◽  
Clinical Presentation ◽  
Lymph Node Biopsy ◽  
Axillary Lymph ◽  
Node Dissection ◽  
Node Biopsy

Axillary Recurrence is Low in Patients with Breast Cancer who do not Undergo Completion Axillary Lymph Node Dissection for Micrometastases in Sentinel Lymph Nodes

2010 ◽  
Vol 76 (10) ◽  
pp. 1088-1091 ◽  
Author(s):  
Jessica Rayhanabad ◽  
Sara Yegiyants ◽  
Krishna Putchakayala ◽  
Philip Haigh ◽  
Lina Romero ◽  
...  
Keyword(s):  
Lymph Node ◽  
Axillary Lymph Node Dissection ◽  
Lymph Node Dissection ◽  
Axillary Lymph Node ◽  
Retrospective Chart Review ◽  
Positive Sentinel Lymph Node ◽  
Lymph Node Biopsy ◽  
Axillary Recurrence ◽  
Axillary Lymph ◽  
Node Dissection

Completion axillary lymph node dissection (CLND) is presently the standard of care after a positive sentinel lymph node biopsy (SLNB). We hypothesize that the incidence of axillary recurrence in patients who do not undergo CLND for micrometastases is low, and CLND is not necessary for locoregional control. We performed a retrospective chart review of patients with invasive breast carcinoma and micrometastases detected on SLNB. The Memorial Sloan Kettering Nomogram (MSKN) predicting the likelihood of nonsentinel lymph node (NSN) metastases was compared with the incidence of positive NSN. There were 61 patients identified with a mean follow-up of 70 months. The average tumor size was 2 cm. The median number of positive SLNs was one. Twenty-eight (46%) patients had a CLND; of these, 20 patients had one positive NSN (2 of 28 [7%]) and the mean MSKN score was 12 per cent. There were 33 (54%) patients who had SLNB alone, and their mean MSKN score was 13 per cent. Axillary recurrence in this group was 1.6 per cent. We conclude the incidence of axillary recurrence in patients with micrometastases detected by SLN biopsy who do not undergo CLND is low. The use of a predictive nomogram to estimate likelihood of metastatic disease to NSN may overestimate the actual incidence of positive NSN in patients with micrometastases.

scholarly journals Quality of Life After Sentinel Lymph Node Biopsy Versus Complete Axillary Lymph Node Dissection in Early Breast Cancer: A 3-Year Follow-up Study

Medicina ◽  
2018 ◽  
Vol 49 (3) ◽  
pp. 18
Author(s):  
Algirdas Boguševičius ◽  
Daiva Čepulienė
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Axillary Lymph Node Dissection ◽  
Lymph Node Dissection ◽  
Axillary Lymph Node ◽  
Lymph Node Biopsy ◽  
Axillary Lymph ◽  
Node Dissection ◽  
Node Biopsy

Background and Objectives. The rating of life quality may belong to the method of surgical treatment: after the axillary lymph node dissection patients may suffer from arm symptoms; after sentinel lymph node biopsy women may highlight the anxiety about the success of radical treatment. The aim was to assess the influence of sentinel lymph node biopsy on the quality of life of the patients with early stage breast cancer compared with total axillary lymph node dissection. Material and Methods. In a prospective case-control study, 48 patients with early invasive breast cancer and no evidence of lymph nodes involvement underwent breast conserving surgery with sentinel lymph node biopsy. They were grouped as matched pairs with the patients who underwert axillary lymph node dissection, according to the age, TNM stage, localization, hormonal receptor status, and surgical characteristics. Quality of life was evaluated using the QLQ-C30 and QLQ-BR-23 questionnaires before surgery and after 1, 3, 6, 12, and 36 months. Results. The patients who underwent sentinel lymph node biopsy scored better on the emotional functioning, pain, sexual functioning, and future perspective scales in comparison with those who underwent axillary lymph node dissection. The score on the arm symptom scale remained significantly better in the sentinel lymph node biopsy group than the axillary lymph node dissection group within the overall follow-up period. Conclusions. The women who underwent sentinel lymph node biopsy experienced better quality of life than the patients who underwent axillary lymph node dissection.

Sign in / Sign up

Export Citation Format

Share Document